Table 1 Patient characteristics
From: Point of care aspergillus testing in intensive care patients
Case | Control | p | |
|---|---|---|---|
n | 55 | 123 | |
Center = Rotterdam (%) | 22 (40.0) | 54 (43.9) | 0.747 |
Age, years (median [IQR]) | 63 [56, 68] | 57 [46, 66] | 0.073 |
Male gender (%) | 34 (61.8) | 66 (53.7) | 0.395 |
Weight, kg (median [IQR]) | 70 [60, 84] | 70 [62, 85] | 0.910 |
Underlying disease (%) | 0.355 | ||
Pulmonary disease | 22 (40.0) | 59 (52.2) | |
Hematologic malignancy | 9 (16.4) | 10 (8.8) | |
Heart disease | 4 (7.3) | 10 (8.8) | |
Liver disease | 3 (5.5) | 5 (4.4) | |
Gastrointestinal disease | 3 (5.5) | 2 (1.8) | |
Other malignancy | 2 (3.6) | 9 (8.0) | |
Other | 12 (21.8) | 18 (15.9) | |
Neutropenia (%) | 8 (17.0) | 7 (5.7) | 0.094 |
Influenza (%) | 17 (30.9) | 47 (38.2) | 0.442 |
COPD (%) | 6 (10.9) | 15 (12.2) | 1.000 |
Positive culture (%) | 28 (50.9) | ||
Positive microscopy (%) | 4 (7.3) | ||
BALf GM (median [IQR]) | 4.80 [2.73, 5.68] |